---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-067797"
form_type: "8-K"
ticker: "KYMR"
cik: "0001815442"
company_name: "Kymera Therapeutics, Inc."
filed_at: "2023-03-10T23:59:59+00:00"
generated_at: "2026-06-18T05:44:31.560531+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Kymera reports limited SVB exposure of $2.2M cash and $4.5M letter of credit

## Summary
- As of March 10, 2023, Kymera holds $2.2M cash at Silicon Valley Bank (SVB) and $4.5M restricted cash letter of credit.
- Total cash and equivalents reported at $560M as of Dec 31, 2022; SVB exposure represents <1% of cash.
- Company does not anticipate any material impact on operations or liquidity from SVB closure.

## SEC filing metadata
- accession: 0001193125-23-067797
- form_type: 8-K
- ticker: KYMR
- cik: 0001815442
- company_name: Kymera Therapeutics, Inc.
- filed_at: 2023-03-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1815442/000119312523067797/0001193125-23-067797-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1815442/000119312523067797/d459968d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-067797
- JSON: https://secwatch.observer/filing/0001193125-23-067797.json
- Plain text: https://secwatch.observer/filing/0001193125-23-067797.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.